EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 3.0

Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials

Chuhan Shao iD, Hanmo Lin, Jie Yu, Haiyan Chen, Yaolin Ren, Jing Ren, Yuan Zeng, Yifan Wu, Haoyu Bai, Qian Zhang, Xinhua Xiao

Diabetes, Metabolic Syndrome and Obesity · 2026-09 · Volume 19 · 1-15

DOI: 10.2147/dmso.s616418 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-09. Verfasst von Chuhan Shao und 10 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Endocrinology (Peking Union Medical College Hospital), Diabetes Research Center of Chinese Academy of Medical Sciences, Departm…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Overweight status, obesity, and diabetes represent significant socioeconomic burdens that require long-term management.

Methods

To evaluate the efficacy and safety of dual-agonist CagriSema vs semaglutide monotherapy, cagrilintide monotherapy, and placebo in adults with overweight/obese status and type 2 diabetes, we searched Embase, MEDLINE, PubMed, and the Cochrane Library up to 14 June 2026 for randomized controlled trials (RCTs). Separate pairwise meta-analyses were conducted using random effects models.

Results

Eight RCTs comprising 6898 participants were included. CagriSema was associated with significantly greater percentage body weight reduction compared to semaglutide [MD -6.60%; 95%CI: -8.51 to -4.68; P

Schlagwörter

Stichwörter der Autor:innen

CagriSemameta-analysisobesityrandomized controlled trialtype 2 diabetes

Autor:innen und Institutionen

  • NHC Key Laboratory of Endocrinology (Peking Union Medical College Hospital), Diabetes Research Center of Chinese Academy of Medical Sciences, Department of Endocrinology, Peking Union Medical College Hospital, Chinese A…

ORCID-Profile: Chuhan Shao

Zitieren

APA

Shao, C., Lin, H., Yu, J., Chen, H., Ren, Y., Ren, J., Zeng, Y., Wu, Y., Bai, H., Zhang, Q., & Xiao, X. (2026). Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-15. https://doi.org/10.2147/dmso.s616418

Vancouver

Shao C, Lin H, Yu J, Chen H, Ren Y, Ren J, et al. Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-15. doi:10.2147/dmso.s616418

BibTeX
@article{Shao2026,
  author = {Shao, Chuhan and Lin, Hanmo and Yu, Jie and Chen, Haiyan and Ren, Yaolin and Ren, Jing and Zeng, Yuan and Wu, Yifan and Bai, Haoyu and Zhang, Qian and Xiao, Xinhua},
  title = {Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials},
  journal = {Diabetes, Metabolic Syndrome and Obesity},
  year = {2026},
  volume = {Volume 19},
  pages = {1--15},
  doi = {10.2147/dmso.s616418}
}
Kostenlos starten →